[1] Fenton KA,Ison C,Johnson AP,et al.Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.Lancet,2003,361(9372):1867-1869. [2] Herida M,Sednaoui P,Goulet V.Gonorrhoea surveillance system in France:1986-2000.Sex Transm Dis,2004,31(4):209-214. [3] Ray K,Bala M,Kumari S,et al.Antimicrobial resistance of Neisseria gonorrhoeae in selected World Health Organization Southeast Asia Region countries:an overview.Sex Transm Dis,2005,32(3):178-184. [4] Tapsall J,Members of the National Neisseria Network of Australia.Antimicrobial testing and applications in the pathogenic Neisseria//Merlino J.Antimicrobial susceptibility testing:methods and practices with an Australian perspective.Sydney:Australian Society for Microbiology,2004:175-188. [5] Gransden WR,Warren CA,Phillips I,et al.Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.Lancet,1990,335(8680):51. [6] Laurie Barclay.CDC issues new treatment recommendations for gonorrhea MMWR,2007,56:332-336. [7] 苏晓红,叶顺章.淋球菌对环丙氟哌酸的敏感性测定.临床皮肤科杂志,1997,26(6):356-358. [8] Ghanem KG,Giles JA,Zenilman JM.Fluoroquinolone-resistant Neisseria gonorrhoeae:the inevitable epidemic.Infect Dis Clin North Am,2005,19(2):351-365. [9] 苏晓红,叶顺章,戴秀芹.氟喹诺酮类药物治疗淋病失败8例报道.中国性病艾滋病防治,2001,(增刊):612-613. |